---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-26-059699"
form_type: "8-K"
ticker: "MMED"
cik: "0002062583"
company_name: "MiniMed Group, Inc."
filed_at: "2026-09-01T10:50:10+00:00"
generated_at: "2026-09-01T10:55:09.822190+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# MiniMed Q1 FY27 net sales $843M +16.6%; raises FY27 organic growth to ~10.5%

## Summary
- Net sales $843M, +16.6% as reported, +15.8% organic; U.S. +13.1% to $240M, international +18.1% to $603M.
- Worldwide NPS ~34,000 (+7.7% YoY); CGM attachment rate 69% (+~100bps QoQ).
- Raises FY27 organic revenue growth to ~10.5% (from ~10%); reaffirms adjusted EBITDA margin ~16%.
- Pipeline: MiniMed Fit FDA submission ahead of Fall; Flex CE Mark; Vivera pivotal enrollment complete; next-gen sensor IDE approved.
- U.S. launch of MiniMed Flex with Instinct started Aug 17; Medicare coverage expanded.

## SEC filing metadata
- accession: 0001628280-26-059699
- form_type: 8-K
- ticker: MMED
- cik: 0002062583
- company_name: MiniMed Group, Inc.
- filed_at: 2026-09-01T10:50:10+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/2062583/000162828026059699/0001628280-26-059699-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/2062583/000162828026059699/mmed-20260901.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-26-059699
- JSON: https://secwatch.observer/filing/0001628280-26-059699.json
- Plain text: https://secwatch.observer/filing/0001628280-26-059699.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.